Use of renal allografts from donors positive for hepatitis B core antibody confers minimal risk for subsequent development of clinical hepatitis B virus disease

Transplantation

Volumn 64, Issue 12, 1997, Pages 1781-1786

  Madayag, Robert M ^a   Johnson, Lynt B ^a   Bartlett, Stephen T ^a   Schweitzer, Eugene J ^a   Constantine, Niel T ^a   McCarter Jr , Robert J ^a   Kuo, Paul C ^a   Keay, Susan ^a   Oldach, David W ^a,b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b INSTITUTE OF HUMAN VIROLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B CORE ANTIBODY;

ADULT; ANTIBODY RESPONSE; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; HEPATITIS B; HUMAN; INFECTION CONTROL; INFECTION RISK; KIDNEY ALLOGRAFT; KIDNEY DONOR; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; SEROCONVERSION; SEROLOGY; VIRUS TRANSMISSION;

ADULT; CADAVER; FEMALE; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B CORE ANTIGENS; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; RISK; TISSUE DONORS;

EID: 0031448949     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199712270-00027     Document Type: Conference Paper

References (24)

1. Parfrey PS, Forbes RDC, Hutchinson TA, et al. The impact of renal transplantation on the course of hepatitis B liver disease. Transplantation 1985; 39: 610.
2. Degos F, Lugassy G, Degott C, et al. Hepatitis B virus and hepatitis B-related viral infection in renal transplant recipients. Gastroenterology 1988; 94: 151.
3. Dusheiko G, Sang E, Bowyer S. Natural history of hepatitis B virus infection in renal transplant recipients: a fifteen year follow-up. Hepatology 1983; 3: 330.
4. Huang G-C, Lai M-K, Wong MT. Hepatitis B liver disease in cyclosporine-treated renal allograft recipients. Transplantation 1990; 49: 540.
5. Gagnadoux MF, Guest G, Ronsse-Nussenzveig P, et al. Long-term outcome of hepatitis B after renal transplantation during childhood. Transplant Proc 1993; 25: 1454.
6. Harnett JD, Zeldis JB, Parfrey PS, et al. Hepatitis B disease in dialysis and renal transplant recipients. Transplantation 1987; 44: 369.
7. Parfrey PS, Forbes RDC, Hutchinson TA, et al. The impact of renal transplantation on the course of hepatitis B liver disease. Transplantation 1985; 39: 610.
8. Chen PM, Fan S, Liu CJ, et al. Changing of hepatitis B virus markers in patients with bone marrow transplantation. Transplantation 1990; 48: 708.
9. Martin BA, Row JM, Kouides PA, et al. Hepatitis B reactivation following allogenic bone marrow transplantation: case report and review of literature. Bone Marrow Transplant 1995; 15: 145.
10. Nagington J, Cossart YE, Cohen BJ. Reactivation of hepatitis B after transplantation operations. Lancet 1977; 1: 588.
11. Chan M, Chang WK. Renal transplantation from HBsAg positive donors to HBsAg negative recipients. Br J Med 1988; 297: 592.
12. Lutwick LT, Sywassink JM, Curry RJ, et al. The transmission of hepatitis B by renal transplantation. Clin Nephrol 1983; 19(6): 317.
13. Wolf JL, Perkins H, Schreeder MT, Vincenti F. The transplanted kidney as a source of hepatitis B infection. Ann Intern Med 1979; 91: 412.
14. Chazouilleres O, Mamish D, Kim M, et al. "Occult" hepatitis B virus as source of infection in liver transplant recipients. Lancet 1994; 343: 142.
15. Wachs ME, Amend WJ, Ascher NL, et al. The risk of transmission of hepatitis B from HBsAg(-), HBcAb(+), HBIgM(-) organ donors. Transplantation 1995; 59: 230.
16. Kadian M, Hawkins K, Schwartz H, Miller C. Use of hepatitis B core antibody-positive multi-organ donors. J Transplant Coord 1994; 4: 57.
17. Rehermann B, Ferrari C, Pasquinelli C, Chisari FV. The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response. Nature Med 1996; 2: 1104.
18. Cox DR, Oakes D. Analysis of survival data. London: Chapman and Hall, 1984.
19. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958. 53: 457.
20. Stevens C, Alter H, Taylor P, Zang E, Harley E, Szmuness W. The Dialysis Vaccine Trial Study Group. Hepatitis B vaccine in patients receiving hemodialysis: immunogenicity and efficacy. N Engl J Med 1984. 311: 496.
21. Brechot C, Degos F, Lugassy C, et al. Hepatitis B virus DNA in patients with chronic liver disease and negative tests for hepatitis B surface antigen. N Engl J Med 1985; 312: 270.
22. Liang TJ, Bodenheimer HC Jr, Yankee R, et al. Presence of hepatitis B and C viral genomes in US blood donors as detected by polymerase chain reaction amplification. J Med Virol 1994; 42: 151.
23. Dodd, RY, Popovsky MA, and Members of the Scientific Section Coordinating Committee. Antibodies to hepatitis B core antigen and the infectivity of the blood supply. Transfusion 1991; 31: 443.
24. Hoofnagle JH, Seef LB, Bales ZB. Type B hepatitis after transfusion with blood containing antibody to hepatitis B core antigen. N Engl J Med 1978; 298: 1379.